NextNav Q2 2026 earnings call: debt-free balance sheet, ~$300M liquidity, SpaceX-backed 900MHz FCC momentum, and new partners.
Emirates News Agency on MSN
Amlak Finance announces its H1 2026 financial results
DUBAI, 11th August, 2026 (WAM) -- Amlak Finance PJSC announced its H1 2026 financial results for the period that ended 30th ...
Nvidia stock rose about 0.3% to around $218 after falling 2.9% on Monday, when the company announced MoUs with several financial institutions to expand access to capital for AI companies purchasing ...
Operator: Good afternoon, and welcome to the Q2 26 Financial Results Conference Call for Intelligent Protection Management Corp. Better known as IPM, for the quarter ended on 06/30/2026. At this time, ...
The evolving role of CFOs as they increasingly step into CEO positions, highlighting Aasif Malbari's appointment at Godrej Consumer Products and the changing landscape of business leadership.
Philstar.com on MSN
Landbank eyes growth this year
MANILA, Philippines — State-run Land Bank of the Philippines is aiming to return to profit growth this year despite the income impact of waiving digital transfer fees and a challenging economic ...
Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, reported financial results for the second quarter ending June 30, 2026 and ...
Realizes Record Quarterly Sales, Gross Profit and EBITDA VANCOUVER, BC AND BREDA, THE NETHERLANDS / ACCESS Newswire / August 11, 2026 / Organto Foods Inc. (TSXV:OGO)(OTCQX:OGOFF)(FSE:OGF0) ("Organto" ...
Zacks Investment Research on MSN
Is WTI worth buying now as relative value meets balance-sheet risk?
W&T Offshore, Inc.WTI presents a mixed investment case. Its forward sales valuation sits below key comparison benchmarks, ...
"We are reaffirming our full year 2026 guidance. We continue to expect revenues to be between $120 million and $125 million and adjusted EBITDA of between $17 million and $20 million for the full year ...
Enrollment in Phase 2 HORIZON trial of MZE829 on track; data from all cohorts expected in late 2026 or early 2027 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results